PANEL DISCUSSION What Went Wrong in Clinical Trials and What Should Have Been Done Differently

  • Sharing real examples of decisions that led to delays inefficiencies or trial failure
  • Understanding early warning signs that were missed or ignored
  • Identifying what should have been done differently in hindsight
  • Applying these lessons to improve future trial design and execution

3 x Biopharma panel seats available

1 x Vendor panel seat available